Hong Zejun increased his shareholding in Shenzhen Hepalink Pharmaceutical Group (09989) by 487,000 shares at HK$3.97 per share.
On October 15, Hong Zejun increased his shareholding in Hepalink (09989) by 487,000 shares at HK$3.97 per share, for a total amount of approximately HK$1.9334 million.
The latest data from the Hong Kong Stock Exchange shows that on October 15, Hong Zejun increased his shareholding in Shenzhen Hepalink Pharmaceutical Group (09989) by 487,000 shares at HK$3.97 per share, for a total amount of approximately HK$1.9334 million. After the increase, his latest shareholding stood at approximately 31.26 million shares, with his latest shareholding ratio at 14.20%.
Related Articles
US Stock Market Move | Lockheed Martin Corporation (LMT.US) rose more than 6% as Q3 revenue grew 11% year-over-year and the company raised its full-year guidance.
NVIDIA Corporation (NVDA.US) GTC Berlin signals 2027 growth! Morgan Stanley positive on supply chain expansion and AI factory efficiency gains, reiterates top pick.
US Stock Market Move | The Procter & Gamble Company (PG.US) rose more than 6%; Coca-Cola Company (KO.US) stock price hit a record high.
US Stock Market Move | Lockheed Martin Corporation (LMT.US) rose more than 6% as Q3 revenue grew 11% year-over-year and the company raised its full-year guidance.
NVIDIA Corporation (NVDA.US) GTC Berlin signals 2027 growth! Morgan Stanley positive on supply chain expansion and AI factory efficiency gains, reiterates top pick.
US Stock Market Move | The Procter & Gamble Company (PG.US) rose more than 6%; Coca-Cola Company (KO.US) stock price hit a record high.
